Roche Holding (SWX:ROP) Received FDA Clearance For An Alzheimer’s Blood Test

Roche Holding (SWX:ROP) announced a collaboration with Treeline Biosciences to study combination immunotherapies for B-cell lymphomas. The partners plan to evaluate advanced immune based treatments aimed at improving options for lymphoma patients. Roche received FDA clearance for its Elecsys pTau217 blood test as the first single biomarker assay to help both rule in and rule out amyloid pathology in Alzheimer’s disease. The Elecsys pTau217 test is intended to support clinicians in earlier...